Hideaki Nagaya

954 total citations
29 papers, 817 citations indexed

About

Hideaki Nagaya is a scholar working on Molecular Biology, Surgery and Gastroenterology. According to data from OpenAlex, Hideaki Nagaya has authored 29 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Surgery and 8 papers in Gastroenterology. Recurrent topics in Hideaki Nagaya's work include Helicobacter pylori-related gastroenterology studies (10 papers), Gastroesophageal reflux and treatments (6 papers) and ATP Synthase and ATPases Research (5 papers). Hideaki Nagaya is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (10 papers), Gastroesophageal reflux and treatments (6 papers) and ATP Synthase and ATPases Research (5 papers). Hideaki Nagaya collaborates with scholars based in Japan and United States. Hideaki Nagaya's co-authors include Nobuhiro Inatomi, Yoshitaka Maki, Hiroshi Satoh, Kentaro Kubo, Akira Nohara, Nobuaki Nakamura, Hiroshi Satoh, Hideki Igata, Takanobu Kuroita and Keiji Kusumoto and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

Hideaki Nagaya

29 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideaki Nagaya Japan 15 319 234 220 122 120 29 817
Chiyuki Yamato Japan 14 153 0.5× 110 0.5× 157 0.7× 34 0.3× 24 0.2× 34 522
Jimmy J. Romero United States 12 282 0.9× 82 0.4× 164 0.7× 17 0.1× 42 0.3× 15 766
Haruo Ohnishi Japan 14 151 0.5× 36 0.2× 181 0.8× 32 0.3× 85 0.7× 55 622
V. A. John Switzerland 17 74 0.2× 43 0.2× 89 0.4× 88 0.7× 54 0.5× 34 716
Dawei Huang China 14 99 0.3× 50 0.2× 232 1.1× 47 0.4× 45 0.4× 32 609
Cong Xie China 17 177 0.6× 52 0.2× 275 1.3× 280 2.3× 24 0.2× 48 813
Luning Sun China 15 79 0.2× 91 0.4× 231 1.1× 36 0.3× 32 0.3× 42 589
W. McKnight Canada 12 248 0.8× 61 0.3× 108 0.5× 18 0.1× 65 0.5× 14 791
R.M. Gaion Italy 17 56 0.2× 31 0.1× 247 1.1× 65 0.5× 99 0.8× 58 715
B.D. Rush United States 12 100 0.3× 76 0.3× 145 0.7× 15 0.1× 23 0.2× 23 698

Countries citing papers authored by Hideaki Nagaya

Since Specialization
Citations

This map shows the geographic impact of Hideaki Nagaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Nagaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Nagaya more than expected).

Fields of papers citing papers by Hideaki Nagaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Nagaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Nagaya. The network helps show where Hideaki Nagaya may publish in the future.

Co-authorship network of co-authors of Hideaki Nagaya

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Nagaya. A scholar is included among the top collaborators of Hideaki Nagaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Nagaya. Hideaki Nagaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kusumoto, Keiji, Hideki Igata, Mami Ojima, et al.. (2011). Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models. European Journal of Pharmacology. 669(1-3). 84–93. 45 indexed citations
2.
Ojima, Mami, Hideki Igata, Masayuki Tanaka, et al.. (2010). In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies. Journal of Pharmacology and Experimental Therapeutics. 336(3). 801–808. 122 indexed citations
3.
Nagaya, Hideaki, et al.. (2005). Novelty Stress Increases Fecal Pellet Output in Mongolian Gerbils: Effects of Several Drugs. Journal of Pharmacological Sciences. 98(4). 411–418. 16 indexed citations
4.
Yamasaki, Masashi, et al.. (2003). Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative. Inflammation Research. 52(5). 206–214. 10 indexed citations
5.
Nagaya, Hideaki, et al.. (2003). Synthesis of Eosinophil Infiltration Inhibitors with Antihistaminic Activity.. Chemical and Pharmaceutical Bulletin. 51(2). 122–133. 25 indexed citations
6.
Ashida, Yasuko, et al.. (2003). Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis. European Journal of Pharmacology. 476(3). 239–247. 13 indexed citations
7.
Kamei, Takayuki, et al.. (2002). Inhibition of Allergic Dermal Inflammation by the Novel Imidazopyridazine Derivative TAK-427 in a Guinea Pig Experimental Model of Eczema. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1283–1290. 17 indexed citations
8.
Nagaya, Hideaki, et al.. (2001). Effects of TAK-637, a Novel Neurokinin-1 Receptor Antagonist, on Colonic Function in Vivo. Journal of Pharmacology and Experimental Therapeutics. 298(2). 559–564. 30 indexed citations
9.
Satoh, Hiroshi, Akio Shino, Fumihiko Sato, et al.. (1997). Role of Endogenous Basic Fibroblast Growth Factor in the Healing of Gastric Ulcers in Rats.. The Japanese Journal of Pharmacology. 73(1). 59–71. 35 indexed citations
10.
Satoh, Hiroshi, Fumihiko Sato, Shoichi Asano, et al.. (1997). Role of Endogenous Basic Fibroblast Growth Factor in the Healing of Gastric Ulcers in Rats. The Japanese Journal of Pharmacology. 73(1). 59–71. 10 indexed citations
11.
Inatomi, Nobuhiro, Hideaki Nagaya, Kenji Takami, Akio Shino, & Hiroshi Satoh. (1991). Effects of a Proton Pump Inhibitor, AG-1749 (Lansoprazole), on Reflux Esophagitis and Experimental Ulcers in Rats.. The Japanese Journal of Pharmacology. 55(4). 437–451. 39 indexed citations
12.
Nagaya, Hideaki, Nobuhiro Inatomi, Akira Nohara, & Hiroshi Satoh. (1991). Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells. Biochemical Pharmacology. 42(10). 1875–1878. 34 indexed citations
13.
Nagaya, Hideaki, Nobuhiro Inatomi, & Hiroshi Satoh. (1991). Differences in the Antisecretory Actions of the Proton Pump Inhibitor AG-1749 (Lansoprazole) and the Histamine H2-Receptor Antagonist Famotidine in Rats and Dogs.. The Japanese Journal of Pharmacology. 55(4). 425–436. 19 indexed citations
14.
Nagaya, Hideaki, Nobuhiro Inatomi, & Hiroshi Satoh. (1991). Differences in the Antisecretory Actions of the Proton Pump Inhibitor AG-1749 (Lansoprazole) and the Histamine H2-Receptor Antagonist Famotidine in Rats and Dogs. The Japanese Journal of Pharmacology. 55(4). 425–436. 5 indexed citations
15.
Nagaya, Hideaki, Hiroshi Satoh, & Yoshitaka Maki. (1987). Possible mechanism of (H++K+)-ATPase inhibition by AG-1749, a proton pump inhibitor. The Japanese Journal of Pharmacology. 43. 6–6. 1 indexed citations
16.
Nagaya, Hideaki, Hiroshi Satoh, & Yoshitaka Maki. (1987). Actions of antisecretory agents on proton transport in hog gastric microsomes. Biochemical Pharmacology. 36(4). 513–519. 18 indexed citations
17.
Satoh, Hiroshi, et al.. (1986). Antisecretory activity of AG-1749, a proton pump inhibitor. The Japanese Journal of Pharmacology. 40. 226–226. 7 indexed citations
18.
Satoh, Hiroshi, et al.. (1986). Spizofurone, a new anti-ulcer agent, increases alkaline secretion in isolated bullfrog duodenal mucosa. European Journal of Pharmacology. 124(1-2). 149–155. 1 indexed citations
19.
Inatomi, Nobuhiro, Hiroshi Satoh, Hideaki Nagaya, & Yoshitaka Maki. (1985). Spizofurone (AG-629) increases gastric mucosal blood flow in dogs: A possible mechanism of its anti-ulcer effect. European Journal of Pharmacology. 110(3). 343–350. 4 indexed citations
20.
Civen, Morton, et al.. (1977). Paradoxical effects of oral metaproterenol on leukocyte adenosine 3',5'-monophosphate (cyclic AMP) levels in vivo.. PubMed. 38(2). 116–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiyuki Yamato Breakdown of academic impact, for papers by Jimmy J. Romero Breakdown of academic impact, for papers by Haruo Ohnishi Breakdown of academic impact, for papers by V. A. John Breakdown of academic impact, for papers by Dawei Huang Breakdown of academic impact, for papers by Cong Xie Breakdown of academic impact, for papers by Luning Sun Breakdown of academic impact, for papers by W. McKnight Breakdown of academic impact, for papers by R.M. Gaion Breakdown of academic impact, for papers by B.D. Rush
Rankless by CCL
2026